BR112015022844A8 - método para determinar a presença ou ausência de anticorpos específicos do doador em uma amostra biológica, sistema e kit para praticar o mesmo - Google Patents

método para determinar a presença ou ausência de anticorpos específicos do doador em uma amostra biológica, sistema e kit para praticar o mesmo Download PDF

Info

Publication number
BR112015022844A8
BR112015022844A8 BR112015022844A BR112015022844A BR112015022844A8 BR 112015022844 A8 BR112015022844 A8 BR 112015022844A8 BR 112015022844 A BR112015022844 A BR 112015022844A BR 112015022844 A BR112015022844 A BR 112015022844A BR 112015022844 A8 BR112015022844 A8 BR 112015022844A8
Authority
BR
Brazil
Prior art keywords
antibody
donor
absence
biological sample
complex
Prior art date
Application number
BR112015022844A
Other languages
English (en)
Other versions
BR112015022844A2 (pt
BR112015022844B1 (pt
Inventor
B Tyan Dolly
Chen Ge
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of BR112015022844A2 publication Critical patent/BR112015022844A2/pt
Publication of BR112015022844A8 publication Critical patent/BR112015022844A8/pt
Publication of BR112015022844B1 publication Critical patent/BR112015022844B1/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a

Abstract

methods of detecting donor-specific antibodies and systems for practicing the same abstract: provided are methods for determining the presence or absence of donor specific antibodies in a biological sample. the methods include mixing a cellular sample from a donor with a biological sample from a recipient under conditions sufficient for recipient immune antibodies, if present, to bind to donor cell surface antigen (ag) to form an immune antibody-ag complex, contacting the mixture with beads comprising an antibody that specifically binds the immune antibody-ag complex (e.g., the ag or immune antibody) on a surface thereof, adding under lysis conditions a detectably-labeled antibody that specifically binds the immune antibody-ag complex bound to the beads, and detecting the presence or absence of the detectably-labeled antibody bound to the immune antibody-ag complex to determine the presence or absence of donor specific antibodies in the biological sample from the recipient. systems and kits for practicing the subject methods are also provided. tradução do resumo resumo "métodos para detecção de anticorpos para doadores específicos e sistemas para pratica destes" são apresentados métodos para determinar a presença ou ausência de anticorpos específicos ao doador in uma amostra biológica. os métodos incluem misturar uma amostra celular a partir de um doador com uma amostra biológica a partir de um recipiente sob condições suficientes para anticorpos imunológicos do recipiente, caso presente, para ligar ao antígeno de superfície de célula doadora (ag) para formar um complexo de anticorpo imunológico ag, por em contato a mistura com microesferas que compreende um anticorpo que se liga especificamente ao complexo de anticorpo imunológico ag (por exemplo, o ag ou o anticorpo imunológico) em uma superfície do mesmo, adicionar sob condições de lise um anticorpo detectavelmente marcado que se liga especificamente ao complexo de anticorpo imunológico ag ligado às microesferas, e detectar a presença ou ausência do anticorpo detectavelmente marcado ligado ao complexo de anticorpo imunológico ag para determinar a presença ou ausência de anticorpos específicos ao doador na amostra biológica a partir do recipiente. os sistemas e os kits para praticar os métodos também são fornecidos.
BR112015022844-5A 2013-03-14 2014-03-13 Método para determinar a presença ou ausência de anticorpos específicos do doador em uma amostra biológica, sistema e kit para praticar o mesmo BR112015022844B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361782003P 2013-03-14 2013-03-14
US61/782,003 2013-03-14
PCT/US2014/026406 WO2014151763A1 (en) 2013-03-14 2014-03-13 Methods of detecting donor-specific antibodies and systems for practicing the same

Publications (3)

Publication Number Publication Date
BR112015022844A2 BR112015022844A2 (pt) 2017-07-18
BR112015022844A8 true BR112015022844A8 (pt) 2019-11-26
BR112015022844B1 BR112015022844B1 (pt) 2023-01-24

Family

ID=51581037

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015022844-5A BR112015022844B1 (pt) 2013-03-14 2014-03-13 Método para determinar a presença ou ausência de anticorpos específicos do doador em uma amostra biológica, sistema e kit para praticar o mesmo

Country Status (8)

Country Link
US (3) US10101337B2 (pt)
EP (2) EP2972348B1 (pt)
JP (1) JP6548631B2 (pt)
CN (1) CN105308457B (pt)
AU (1) AU2014236882B2 (pt)
BR (1) BR112015022844B1 (pt)
CA (1) CA2905954C (pt)
WO (1) WO2014151763A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009322607B2 (en) 2008-12-01 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detection of complement fixing antibodies
EP2972348B1 (en) 2013-03-14 2018-08-15 The Board of Trustees of The Leland Stanford Junior University Methods of detecting donor-specific antibodies
US10527613B2 (en) 2015-11-10 2020-01-07 The Board Of Trustees Of The Leland Stanford Junior University Biomarker detection methods and systems and kits for practicing same
WO2018039637A1 (en) * 2016-08-26 2018-03-01 Juno Therapeutics, Inc. Methods of enumerating particles present in a cell composition
JP6952295B2 (ja) * 2016-09-09 2021-10-20 国立大学法人金沢大学 ヒト抗ｈｌａモノクローナル抗体の作製方法
CN110178034A (zh) * 2017-01-18 2019-08-27 埃森仪器公司Dba埃森生物科学公司 用于从生物样品中测定免疫球蛋白γ(IgG)抗体同种型浓度的方法和试剂
CN107976535B (zh) * 2017-11-03 2020-03-20 科美诊断技术股份有限公司 一种检测样本中目标IgM抗体的均相免疫检测试剂盒及其使用方法和应用
JP2022531660A (ja) * 2019-05-06 2022-07-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 移植拒絶反応の非ｈｌａマーカー
CN111257566B (zh) * 2020-01-22 2023-03-24 苏州才博医学科技有限公司 用于检测同种异体的、或供者特异性的非hla抗体的方法
CN111413505B (zh) * 2020-04-08 2023-03-24 苏州才博医学科技有限公司 全面检测非hla类供者特异性抗体的细胞学方法
CN112924696A (zh) * 2021-01-27 2021-06-08 浙江大学 一种检测人绒毛滋养细胞外泌体hla-e水平评估母胎免疫耐受的方法
CN114019154A (zh) * 2021-11-09 2022-02-08 河北博因生物科技有限公司 基于流式细胞术用于补体检测的试剂盒及制备方法和应用
CN115125251B (zh) * 2022-08-22 2023-11-03 广东忠信生物科技有限公司 一种高效获得特异性全人单克隆抗体基因的方法和应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS501571A (pt) 1973-08-28 1975-01-09
JPS60500673A (ja) 1983-03-08 1985-05-09 コモンウエルス　セラム　ラボラトリ−ズ　コミツシヨン 抗原活性を有するアミノ酸配列
US5035995A (en) 1984-10-02 1991-07-30 Calpis Food Industry Co., Ltd. Test method involving substance-conjugated complement component C1q
JPS6184560A (ja) 1984-10-02 1986-04-30 Karupisu Shokuhin Kogyo Kk 補体結合性抗体の測定法
JPS61245060A (ja) 1985-04-23 1986-10-31 Takara Shuzo Co Ltd ヒト補体１ｑ定量用キツト及び定量法
JPS6225994A (ja) 1985-05-30 1987-02-03 ジエネテイツク　システムズ　コ−ポレイシヨン Ｈｌａタイプ分け用モノクロ−ナル抗体
IL84160A0 (en) 1986-10-16 1988-03-31 Vasocor Method and kit for immune complex assay
US5176998A (en) 1986-12-01 1993-01-05 The Scripps Research Institute Cell surface antigen detection method
EP0552241B1 (en) 1990-10-10 2000-06-28 The University Of Maryland Method and apparatus for performing phase fluorescence lifetime measurements in flow cytometry
US5223397A (en) 1991-06-05 1993-06-29 Sangstat Medical Corporation Soluble hla cross-match
US5270169A (en) 1992-06-23 1993-12-14 Sangstat Medical Corporation Detection of HLA antigen-containing immune complexes
PT651805E (pt) 1992-07-17 2007-02-28 Dana Farber Cancer Inst Inc Método de ligação intracelular de moléculas-alvo
US5851829A (en) 1993-07-16 1998-12-22 Dana-Farber Cancer Institute Method of intracellular binding of target molecules
GB9502112D0 (en) 1995-02-03 1995-03-22 British Biocell Int Assay device and method
US6159748A (en) 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
US5948627A (en) 1997-05-30 1999-09-07 One Lambda Immunobead flow cytometric detection of anti-HLA panel-reactive antibody
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
AU759779B2 (en) 1997-10-31 2003-05-01 Genentech Inc. Methods and compositions comprising glycoprotein glycoforms
US6682940B2 (en) 1999-05-04 2004-01-27 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
AU2002336417A1 (en) 2001-08-31 2003-03-18 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Methods of generating human cd4+ th1 cells
CN1423130A (zh) 2002-04-26 2003-06-11 帕弗瑞生物技术(北京)有限公司 流式测定固定补体抗体的hla交叉配型方法和试剂盒
CN1444044A (zh) 2002-06-18 2003-09-24 帕弗瑞生物技术(北京)有限公司 以酶联免疫测定为基础的hla补体依赖性细胞毒性抗体检测方法和试剂盒
TW200508609A (en) * 2003-07-15 2005-03-01 Bioarray Solutions Ltd Detection of cell membrane-associated proteins using membrane fragments displayed on encoded microparticle arrays
US20050277158A1 (en) 2004-06-10 2005-12-15 Ge Chen Method and kit for donor specific complement-fixing antibodies crossmatch
US7799556B2 (en) 2004-06-17 2010-09-21 George Dacai Liu System and method for antigen structure-independent detection of antigens captured on antibody arrays
CA2606916A1 (en) 2005-05-06 2006-11-16 Platypus Technologies, Llc Liquid crystal based analyte detection
CN100354629C (zh) 2005-10-17 2007-12-12 中国人民解放军第三军医大学第一附属医院 用胶体金标记补体第一成分q亚单位做指示剂的蛋白芯片/微阵列检测系统及检测方法
US8722419B2 (en) 2006-06-22 2014-05-13 Massachusetts Institute Of Technology Flow cytometry methods and immunodiagnostics with mass sensitive readout
GB0618496D0 (en) 2006-09-20 2006-11-01 Common Services Agency Blood typing
JP2008100986A (ja) 2006-09-21 2008-05-01 Takahiro Ochi Ｃ１ｑ結合物質、ならびにその使用
US8603950B2 (en) 2007-02-20 2013-12-10 Anaptysbio, Inc. Methods of generating libraries and uses thereof
US7964350B1 (en) * 2007-05-18 2011-06-21 Applied Biosystems, Llc Sample preparation for in situ nucleic acid analysis
JP2009080019A (ja) 2007-09-26 2009-04-16 Nippon Sekijiyuujishiya 蛍光ビーズを用いた免疫複合体検出による抗体解析法
DE102008045696A1 (de) * 2008-09-04 2010-03-11 Drk Blutspendedienst West Ggmbh Granulozyten HNA-3a/b-Antigen
AU2009322607B2 (en) * 2008-12-01 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detection of complement fixing antibodies
AU2010254259A1 (en) * 2009-05-29 2012-01-12 Emory University B cell signature associated with tolerance in transplant recipients
US9637719B2 (en) 2013-12-06 2017-05-02 Douglas T. Gjerde Devices and methods for purification of biological cells
US20120065092A1 (en) 2010-09-14 2012-03-15 Wai Hobert Fusion analyte cytometric bead assay, and systems and kits for performing the same
EP2751574A4 (en) * 2011-08-30 2015-02-18 Univ Alberta METHOD AND SYSTEM FOR DETECTION AND CHARACTERIZATION OF ABO ANTIBODIES
US20160041185A1 (en) 2013-03-14 2016-02-11 The Board Of Trustees Of The Leland Stanford Junior University Methods of Detecting Complement Fixing and Non-Complement Fixing Antibodies and Systems for Practicing the Same
EP2972348B1 (en) * 2013-03-14 2018-08-15 The Board of Trustees of The Leland Stanford Junior University Methods of detecting donor-specific antibodies
SG11201507781VA (en) 2013-03-18 2015-10-29 Biocerox Prod Bv Humanized anti-cd134 (ox40) antibodies and uses thereof
EP3146337B1 (en) 2014-05-23 2020-05-27 Firefly Bioworks, Inc. Substrate-mediated reactors for bioassays
MA41414A (fr) 2015-01-28 2017-12-05 Centre Nat Rech Scient Protéines de liaison agonistes d' icos
US11116795B2 (en) 2015-07-10 2021-09-14 The Trustees Of The University Of Pennsylvania Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor
US10527613B2 (en) 2015-11-10 2020-01-07 The Board Of Trustees Of The Leland Stanford Junior University Biomarker detection methods and systems and kits for practicing same

Also Published As

Publication number Publication date
WO2014151763A1 (en) 2014-09-25
AU2014236882B2 (en) 2019-01-31
US10101337B2 (en) 2018-10-16
EP2972348A1 (en) 2016-01-20
US20160033524A1 (en) 2016-02-04
CN105308457B (zh) 2018-07-10
CN105308457A (zh) 2016-02-03
BR112015022844A2 (pt) 2017-07-18
US20210199662A1 (en) 2021-07-01
US10746744B2 (en) 2020-08-18
BR112015022844B1 (pt) 2023-01-24
CA2905954C (en) 2022-03-22
EP2972348B1 (en) 2018-08-15
CA2905954A1 (en) 2014-09-25
JP2016515215A (ja) 2016-05-26
EP3435080A1 (en) 2019-01-30
US20190079096A1 (en) 2019-03-14
JP6548631B2 (ja) 2019-07-24
US11796547B2 (en) 2023-10-24
EP2972348A4 (en) 2016-08-31
AU2014236882A1 (en) 2015-09-24

Similar Documents

Publication Publication Date Title
BR112015022844A8 (pt) método para determinar a presença ou ausência de anticorpos específicos do doador em uma amostra biológica, sistema e kit para praticar o mesmo
HRP20201856T1 (hr) Antitijela koja se vežu za ljudski ligand i programiranje smrti (pd-l1)
MX2020009021A (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.
BRPI0923199B8 (pt) método para determinar a presença de anticorpos de fixação de complemento
MX362075B (es) Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
BR112014025384A8 (pt) método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares
MX2014001377A (es) Metodo para detectar cancer pancreatico.
NZ603084A (en) Multiple analysis of blood samples
BR112015023355A2 (pt) antígenos recombinantes ns3 de hcv e mutantes dos mesmos para detecção de anticorpos aprimorada
JP2016515215A5 (pt)
BR112017021686A2 (pt) método para detectar uma ou várias carbapenemases, dispositivo para detectar imunocromatográfico e uso do dispositivo para detectar imunocromatográfico
MX2013003161A (es) Dispositivos, metodos y kits de inmunocromatografia.
BRPI0820885B8 (pt) "anticorpo ou fraguimento do mesmo, célula de hibridoma, polinucleotídeo, polipeptídeo compreendendoum domínio de cadeia pesada ou leve de anticorpo, método para detecção de gravidez em um animal bovino, kit e método de purificação de um antígeno principal associado à gravidez (pag)".
BR112014020513A2 (pt) Métodos e sistemas para amplificação de sinal de bioensaios
BR112017022329A2 (pt) métodos para detectar aglutinação e composições para uso na prática do mesmo
MX2011009020A (es) Ensayo sin separacion con inhibidores de señal selectiva.
MY193489A (en) Immunochromatography test piece for extracting and measuring sugar chain antigen, which is capable of preventing non-specific reaction
BR112018007842A2 (pt) imunoensaio para a detecção de cininogênio clivado de alto peso molecular, método, anticorpo isolado, kit para detectar um cininogênio de alto peso molecular clivado (hmwk)
BR112012029769A2 (pt) processo para a detecção eletroquímica de reações de ligação
RU2015104737A (ru) Способ обнаружения мультиспецифического связывающего агента
BR112013024686A2 (pt) ensaio de psa, e, reagente de ensaio de psa
EA201370030A1 (ru) Бифункциональный количественный анализ in vitro связывания мишени для обнаружения нейтрализующих антител к антителам-мишеням
WO2011003598A3 (de) Detektion von antigenen
EP4253950A3 (en) Ce-western applications for antibody development
MX2017005156A (es) Metodo para determinacion de anticuerpos de anti-farmaco contra anticuerpo de farmaco humano o humanizado de funcion efectora suprimida.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/03/2014, OBSERVADAS AS CONDICOES LEGAIS